Martin T R, Mathison J C, Tobias P S, Letúrcq D J, Moriarty A M, Maunder R J, Ulevitch R J
Medical Research Service, Seattle Veterans Affairs Medical Center, Washington.
J Clin Invest. 1992 Dec;90(6):2209-19. doi: 10.1172/JCI116106.
A plasma lipopolysaccharide (LPS)-binding protein (LBP) has been shown to regulate the response of rabbit peritoneal macrophages and human blood monocytes to endotoxin (LPS). We investigated whether LBP is present in lung fluids and the effects of LBP on the response of lung macrophages to LPS. Immunoreactive LBP was detectable in the lavage fluids of patients with the adult respiratory distress syndrome by immunoprecipitation followed by Western blotting, and also by specific immunoassay. In rabbits, the LBP appeared to originate outside of the lungs, inasmuch as mRNA transcripts for LBP were identified in total cellular RNA from liver, but not from lung homogenates or alveolar macrophages. Purified LBP enhanced the response of human and rabbit alveolar macrophages to both smooth form LPS (Escherichia coli O111B:4) and rough form LPS (Salmonella minnesota Re595). In the presence of LBP and LPS, the onset of tumor necrosis factor-alpha (TNF alpha) production occurred earlier and at an LPS threshold dose that was as much as 1,000-fold lower for both types of LPS. In rabbit alveolar macrophages treated with LBP and LPS, TNF alpha mRNA appeared earlier, reached higher levels, and had a prolonged half-life as compared with LPS treatment alone. Neither LPS nor LPS and LBP affected pHi or [Cai++] in alveolar macrophages. Specific monoclonal antibodies to CD14, a receptor that binds LPS/LBP complexes, inhibited TNF alpha production by human alveolar macrophages stimulated with LPS alone or with LPS/LBP complexes, indicating the importance of CD14 in mediating the effects of LPS on alveolar macrophages. Thus, immunoreactive LBP accumulates in lung lavage fluids in patients with lung injury and enhances LPS-stimulated TNF alpha gene expression in alveolar macrophages by a pathway that depends on the CD14 receptor. LBP may play an important role in augmenting TNF alpha expression by alveolar macrophages within the lungs.
血浆脂多糖(LPS)结合蛋白(LBP)已被证明可调节兔腹膜巨噬细胞和人血单核细胞对内毒素(LPS)的反应。我们研究了LBP是否存在于肺液中以及LBP对肺巨噬细胞对LPS反应的影响。通过免疫沉淀后进行蛋白质印迹法,以及通过特异性免疫测定法,可在成人呼吸窘迫综合征患者的灌洗液中检测到免疫反应性LBP。在兔中,LBP似乎起源于肺外,因为在肝脏的总细胞RNA中鉴定出了LBP的mRNA转录本,而在肺匀浆或肺泡巨噬细胞中未鉴定出。纯化的LBP增强了人和兔肺泡巨噬细胞对光滑型LPS(大肠杆菌O111B:4)和粗糙型LPS(明尼苏达沙门氏菌Re595)的反应。在LBP和LPS存在的情况下,肿瘤坏死因子-α(TNFα)产生的起始时间更早,且对于两种类型的LPS,其LPS阈值剂量低至1000倍。与单独用LPS处理相比,用LBP和LPS处理的兔肺泡巨噬细胞中,TNFαmRNA出现更早、水平更高且半衰期延长。LPS以及LPS和LBP均不影响肺泡巨噬细胞中的细胞内pH值(pHi)或钙离子浓度([Cai++])。针对CD14(一种结合LPS/LBP复合物的受体)的特异性单克隆抗体,可抑制单独用LPS或用LPS/LBP复合物刺激的人肺泡巨噬细胞产生TNFα,这表明CD14在介导LPS对肺泡巨噬细胞的作用中具有重要性。因此,免疫反应性LBP在肺损伤患者的肺灌洗液中蓄积,并通过依赖于CD14受体的途径增强LPS刺激的肺泡巨噬细胞中TNFα基因的表达。LBP可能在增强肺内肺泡巨噬细胞的TNFα表达中起重要作用。